CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Option exercise Director acquired 1,424 shares (option exercise)
- 4 Grant or award Director acquired 1,372 shares (grant or award)
- 4 Grant or award Director acquired 1,246 shares (grant or award)
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- 8-K Event Executive or director change
- 4/A Shares withheld for taxes Chief Legal Officer gave up 1,102 shares (to pay taxes)
- 4/A Shares withheld for taxes President & CEO gave up 3,675 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Scientific Officer gave up 1,102 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Financial Officer gave up 1,102 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief People Officer gave up 1,102 shares (to pay taxes)
- 4/A Shares withheld for taxes Chief Medical Officer gave up 1,102 shares (to pay taxes)
Page 18 of 28 · 549 filings